Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
International Journal of Cancer|November 13, 2004
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarkerGang Zeng, Michael E Aldridge, Yu Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell linesYangbing Zhao, Alan D Bennett, Zhili Zheng, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Nature Communications|January 27, 2019
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patientsGal Cafri, Rami Yossef, Anna Pasetto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Microbiology Spectrum|September 20, 2022
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 VirusesYi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
International Journal of Cancer|November 13, 2004
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarkerGang Zeng, Michael E Aldridge, Yu Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell linesYangbing Zhao, Alan D Bennett, Zhili Zheng, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Nature Communications|January 27, 2019
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patientsGal Cafri, Rami Yossef, Anna Pasetto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Microbiology Spectrum|September 20, 2022
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 VirusesYi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Pageof 26